[Thyroid cancer: metabolic treatment and follow-up using thyroglobulin levels and I-131 gammagraphy].
Lampreave
J L
JL
Servicio de Medicina Nuclear, Hospital General Universitario Gregorio Marañón, Madrid.
Trampal
C
C
Domínguez
P
P
Bittini
A
A
D000230:Adenocarcinoma / Q000000981:diagnostic imaging / Q000532:radiotherapy / Q000628:therapy*; D018263:Adenocarcinoma, Follicular / Q000000981:diagnostic imaging / Q000532:radiotherapy / Q000628:therapy*; D000328:Adult; D018276:Carcinoma, Medullary / Q000000981:diagnostic imaging / Q000532:radiotherapy / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007457:Iodine Radioisotopes / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011877:Radionuclide Imaging; D013954:Thyroglobulin / Q000097:blood*; D013964:Thyroid Neoplasms / Q000000981:diagnostic imaging / Q000532:radiotherapy / Q000628:therapy*; D013997:Time Factors
D007457:Iodine Radioisotopes; D013954:Thyroglobulin
Cáncer de tiroides: tratamiento metabólico y seguimiento con niveles de tiroglobulina y gammagrafía con 131I.